ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, T. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, T. O.
Related Collections
Right arrow Valve disease
Right arrowRelated Article

Ann Thorac Surg 2001;71:397
© 2001 The Society of Thoracic Surgeons

Correspondence

Reversibility of anorexigenic valvulopathy

Tsung O. Cheng, MDa

a Division of Cardiology, George Washington University Medical Center, 2150 Pennsylvania Ave, NW, Washington, DC 20037, USA

To the Editor

I read with interest the case report of cardiac allograft valvulopathy from a donor with antemortem use of fenfluramine-phentermine for the preceding 8 months [1]. Despite removal of the heart from the causative environment, the allograft valvulopathy progressed. This case is contrary to the recent reports that dexfenfluramine-induced valvulopathy may regress after cessation of its use [2, 3]. Does it mean that the mitral valve in a transplanted, and therefore denervated, heart reacts differently from a native valve to cessation of the use of fenfluramine-phentermine?

References

  1. Prasad A., Mehra M., Park M., Scott R., Uber P.A., McFadden P.M. Cardiac allograft valvulopathy: a case of donor-anorexigen-induced valvular disease. Ann Thorac Surg 1999;68:1840-1841.[Abstract/Free Full Text]
  2. Shively B.K., Rolden C.A., Gill F.A., Najarian T., Loar S.B. Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine. Circulation 1999;100:2161-2167.[Abstract/Free Full Text]
  3. Hensrud D.D., Connolly H.M., Grogan M., Miller F.A., Bailey K.R., Jensen M.D. Echocardiographic improvement over time after cessastion of use of fenfluramine and phentermine. Mayo Clin Proc 1999;74:1191-1197.[Abstract]

Related Article

Reversibility of anorexigenic valvulopathy: Reply
Mandeep R. Mehra
Ann. Thorac. Surg. 2001 71: 397. [Extract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, T. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, T. O.
Related Collections
Right arrow Valve disease
Right arrowRelated Article

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS